Ovarian Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with epithelial ovarian cancer (a specific type of ovarian cancer that starts in the cells covering the ovary)
- People who are 18 years of age or older
- People whose cancer diagnosis has been confirmed through laboratory examination of tissue samples
- People whose genetic testing has shown a specific type of inherited gene change, classified as pathogenic or likely pathogenic according to standard American guidelines for interpreting genetic variants
Who may not be able to join:
- People whose ovarian cancer has been confirmed by tissue testing to be a non-epithelial type (meaning it started in a different type of cell in the ovary)
- People who have not yet had genetic testing carried out
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Hongyan Guo, Doctor, Peking University Third Hospital
Phone: 18610689868
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
The clinicopathological features and gene mutation characteristics of hereditary ovarian cancer
Can't join this trial?
Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.